Amylyx launches expanded access program for post-bariatric hypoglycemia drug
Go back to Amylyx launches expanded access program for post-bariatric hypoglycemia drug| (NASDAQ: AMLX) | Delayed: 16.27 +0.60 (3.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.67 | 52 Week High | $ | |||
| Open | $15.91 | 52 Week Low | $ | |||
| Day High | $16.32 | P/E | N/A | |||
| Day Low | $15.73 | EPS | $ | |||
| Volume | 991,687 | |||||

